Holen Sie sich die Stockscreener-App
156.21
1.88%
2.8501
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt DVA?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$153.36
Offen:
$153
24-Stunden-Volumen:
352.61K
Relative Volume:
0.41
Marktkapitalisierung:
$13.45B
Einnahmen:
$12.67B
Nettoeinkommen (Verlust:
$827.68M
KGV:
16.85
EPS:
9.27
Netto-Cashflow:
$1.42B
1W Leistung:
+4.52%
1M Leistung:
+6.56%
6M Leistung:
-2.86%
1J Leistung:
+18.91%
1-Tages-Spanne:
$151.84
$157.12
1-Wochen-Bereich:
$141.91
$157.12
52-Wochen-Spanne:
$125.64
$179.60
Davita Inc Stock (DVA) Company Profile
Firmenname
Davita Inc
Sektor
Branche
Telefon
310-536-2668
Adresse
2000 16TH STREET, DENVER, CO
Vergleichen Sie DVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
156.51 | 13.45B | 12.67B | 827.68M | 1.42B | 9.27 |
|
HCA
Hca Healthcare Inc
|
335.98 | 82.48B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.96 | 13.98B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
124.15 | 12.06B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
176.09 | 11.62B | 15.42B | 1.03B | 956.84M | 15.02 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-08-07 | Hochstufung | UBS | Neutral → Buy |
| 2022-11-01 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-31 | Herabstufung | UBS | Buy → Neutral |
| 2022-08-19 | Fortgesetzt | UBS | Buy |
| 2022-06-21 | Bestätigt | BofA Securities | Underperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-08-12 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-03-26 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-24 | Hochstufung | Goldman | Neutral → Buy |
| 2019-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2018-12-14 | Eingeleitet | Barclays | Overweight |
| 2018-11-28 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | Eingeleitet | UBS | Sell |
| 2018-11-08 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2018-01-04 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2017-12-07 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2017-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2016-12-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
Alle ansehen
Davita Inc Aktie (DVA) Neueste Nachrichten
Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and Addus HomeCare - TradingView
DaVita HealthCare (DVA) Gains As Market Dips: What You Should Know - Yahoo Finance
DaVita lifts annual profit forecast on strong kidney dialysis services demand - MarketScreener
Q4 Earnings Outperformers: DaVita (NYSE:DVA) And The Rest Of The Outpatient & Specialty Care Stocks - Yahoo Finance
Lobbying Update: $30,000 of DAVITA INC. lobbying was just disclosed - Nasdaq
Large Denver employer plans seven-story apartment building in downtown - 9News
Details revealed about large Denver employer’s downtown workforce housing development - The Business Journals
Lobbying Update: $70,000 of DAVITA INC. lobbying was just disclosed - Nasdaq
Allen learns about dialysis legislation - Statesboro Herald
DaVita HealthCare (DVA) Stock Moves -0.36%: What You Should Know - Yahoo Finance
Te Ahumairangi Investment Management Ltd Has $6.31 Million Stock Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
Is There An Opportunity With DaVita Inc.'s (NYSE:DVA) 45% Undervaluation? - Yahoo Finance
DaVita Stock Declines 1.2% in 3 Months: Here's How to Play - MSN
Denver’s DaVita Inc. at the centre of kickback allegations - MSN
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
How Is DaVita's Stock Performance Compared to Other Health Care Services Stocks? - Nasdaq
How Is DaVita's Stock Performance Compared To Other Health Care Services Stocks? - Barchart.com
Warren Buffett Sold These 12 Stocks Over the Past 6 Months: Should You Sell Them Too? - The Motley Fool
DaVita HealthCare (DVA) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
DaVita Inc. (DVA) Stock Forecasts - Yahoo Finance
DaVita's Dialysis Business Is Surrounded by a Narrow Moat - Morningstar
Why DaVita Inc. (NYSE:DVA) Looks Like A Quality Company - Yahoo Finance
DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
DaVita Inc (DVA) Stock Price Up 0.67% on Mar 19 - GuruFocus.com
The DaVita Dilemma: Flat Patient Enrollment And Lawsuits, Yet An Improvement In Net Income Margin - Seeking Alpha
DaVita (DVA) Shares Decline as Berkshire Hathaway Reduces Stake - GuruFocus.com
Is DaVita Inc. (DVA) the Best Healthcare Stock For Long-Term Investment? - Insider Monkey
US Bancorp DE Sells 1,098 Shares of DaVita Inc. (NYSE:DVA) - Defense World
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Charles Schwab Investment Management Inc. Has $73.17 Million Stock Position in DaVita Inc. (NYSE:DVA) - Defense World
SBI Securities Co. Ltd. Invests $41,000 in DaVita Inc. (NYSE:DVA) - Defense World
Flexibility of a Home Dialysis Nurse - CSRwire.com
DaVita at Barclays Healthcare Conference: Strategic Insights Amid Challenges - Investing.com
3 Reasons to Sell DVA and 1 Stock to Buy Instead - The Globe and Mail
Mutual of America Capital Management LLC Sells 281 Shares of DaVita Inc. (NYSE:DVA) - Defense World
Flexibility Of A Home Dialysis Nurse - MENAFN.COM
CADE challenges DaVita’s acquisition of Brasnefro — Conselho Administrativo de Defesa Econômica - www.gov.br
Is Now An Opportune Moment To Examine DaVita Inc. (NYSE:DVA)? - Simply Wall St
DaVita Inc (DVA) to Participate in Barclays Global Healthcare Conference 2025 - GuruFocus.com
DaVita: A Buffett-Backed Healthcare Stock Worth Watching - Forbes
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2025 - PR Newswire
Sanctuary Advisors LLC Acquires New Position in DaVita Inc. (NYSE:DVA) - Defense World
Day in the Life: Cristina, DaVita PD Registered Nurse - CSRwire.com
Bank of New York Mellon Corp Decreases Stock Holdings in DaVita Inc. (NYSE:DVA) - Defense World
Finanzdaten der Davita Inc-Aktie (DVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.71%
1.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):